Richard Sproll
@Tejara Capital Ltd
Latest period2024 - Q3ReportedManaged Assets$209.862MTotal holdings56
Assets growth rate-23.7%Assets growth rate (2-Q avg)-11.31%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Tejara Capital Ltd's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 56 positions.
Assets under management
The assets under management (AUM) of Tejara Capital Ltd over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 209.862M in assets, with a quarterly growth rate of -23.7% and a 2-quarter average growth rate of -11.31%. The portfolio is managed by Richard Sproll, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
MREOMereo Biopharma Group Plc
| 5.55% | $11.631M 2.83M shares@ $4.12 avg price | Increased 8.21% |
HRTXHeron Therapeutics Inc
| 5.04% | $10.559M 5.306M shares@ $2.0 avg price | Increased 26.7% |
NOVNov Inc
| 4.32% | $9.065M 567,600 shares@ $15.97 avg price | Increased 5.25% |
SLBSchlumberger Ltd
| 3.33% | $6.968M 166,114 shares@ $41.95 avg price | Increased 111.89% |
NENoble Corp Plc
| 3.08% | $6.447M 169,003 shares@ $38.15 avg price | Increased 16.2% |
NXENexgen Energy Ltd
| 2.68% | $5.621M 860,736 shares@ $6.53 avg price | Increased 0.34% |
SSYSStratasys Ltd
| 1.88% | $3.932M 473,216 shares@ $8.32 avg price | Increased 3.87% |
CRDLCardiol Therapeutics Inc
| 1.68% | $3.507M 1.771M shares@ $1.99 avg price | Increased 2.85% |
HALHalliburton Co
| 1.4% | $2.919M 100,489 shares@ $29.05 avg price | Increased 100.98% |
QDELQuidelortho Corp
| 1.16% | $2.418M 53,020 shares@ $45.6 avg price | Increased 19.42% |